Phase III randomized, placebo (PL)-controlled, double-blind study of intravenous calcium/magnesium (CaMg) to prevent oxaliplatin-induced sensory neurotoxicity (sNT), N08CB: An Alliance for Clinical Trials in Oncology study
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 3501
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2111
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- C. L. Loprinzi R. Qin S. R. Dakhil L. Fehrenbacher P. J. Stella P. Atherton D. Seisler R. Qamar G. C. Lewis A. Grothey
- Networks:
- Study
- NCCTG-N08CB
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: